How Ozempic helps manage fatty liver disease Ozempic's active ingredient is semaglutide, a GLP-1 receptor agonist that manages blood sugar by increasing insulin levels, slowing gastric emptying ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target obesity drug to reach the market.

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Discover how Ozempic is transforming America's eating, shopping, and dressing habits, with insights from Dr. Alexandra Sowa's book.